Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Prader-Willi Syndrome Market - 2025-2033
US$ 3,400.00
Prader-Willi Syndrome Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Prader-Willi Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analy...
April 2025
47 pages
Global Influenza Market – Vaccines and Therapeutics
US$ 4,500.00
... a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining ... analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe ...
April 2025
387 pages
Europe Pain Management Drugs Market - 2025-2033
US$ 2,499.00
Europe Pain Management Drugs Market reached US$ 17.13 billion in 2024 and is expected to reach US$ 33.77 billion by 2033, growing with a CAGR of 7.90% during the forecast period 2026-2033. The Europe...
April 2025
54 pages
Compounding Chemotherapy Market By Dose type (Chemotherapeutic, Non-chemotherapeutic), By Compounding Type (Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing, Pharmaceutical Dosage Alteration), By Delivery method (Gravimetric automated Compounding Device, Volumetric Automated Compounding Device), By Sterility (Sterile, Non-sterile), By Technology (With Robotic arm, Without Robotic Arm): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The compounding chemotherapy market was valued at $5,267.03 million in 2024 and is estimated to reach $9,826.7 million by 2034, exhibiting a CAGR of 6.4% from 2025 to 2034.Compounding chemotherapy inv...
April 2025
364 pages
Dermatophytic Onychomycosis Treatment Market Forecasts to 2032 – Global Analysis By Product Type (Tablets, Nail Paints/Lacquers, Ointments & Creams, Laser Therapy Devices, Photodynamic Therapy (PDT) Solutions, and Other Product Types), Route of Administration, Treatment, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dermatophytic Onychomycosis Treatment Market is accounted for $5.7 billion in 2025 and is expected to reach $10.8 billion by 2032 growing at a CAGR of 9.5% dur...
April 2025
150 pages
Vaccine Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2025-2033
US$ 2,999.00
The global vaccine market size reached USD 59.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 136.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.12% during 202...
April 2025
144 pages
Gaucher Disease Pipeline Insights 2025 2026
US$ 2,999.00
The Gaucher Disease Pipeline Insights 2025 was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
March 2025
210 pages
IgA Nephropathy Drugs Market - 2024-2031
US$ 3,400.00
IgA Nephropathy Drugs Marketis is growing with a CAGR of 18.10% during the forecast period 2026-2035. The IgA Nephropathy Drugs Market emerges as a key focus in DataM Intelligence latest in-depth anal...
March 2025
47 pages
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030
US$ 2,970.00
The global clinical trial services market is projected to reach USD 101.86 billion in 2030 from USD 66.59 billion in 2025, growing at a CAGR of 8.9% during the forecast period. This market is expandin...
March 2025
522 pages
Global Gaucher Disease Treatment Market - 2025-2033
US$ 3,400.00
Global Gaucher Disease Treatment Marketis is growing with a CAGR of 2.90% during the forecast period 2026-2035. The Global Gaucher Disease Treatment Market emerges as a key focus in DataM Intelligence...
March 2025
58 pages
Hurler Syndrome Treatment Market - 2025-2033
US$ 3,400.00
Hurler Syndrome Treatment Market reached US$ 377.65 million in 2024 and is expected to reach US$ 529.34 million by 2033, growing with a CAGR of 3.90% during the forecast period 2026-2033. The Hurler S...
March 2025
51 pages
Hydronephrosis Market - 2024-2031
US$ 3,400.00
Hydronephrosis Marketis is growing with a CAGR of 9.50% during the forecast period 2026-2035. The Hydronephrosis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where sea...
March 2025
40 pages
Alpha Thalassemia Market - 2024-2031
US$ 3,400.00
Alpha Thalassemia Market reached US$ 1.1 billion in 2022 and is expected to reach US$ 1.9 billion by 2031, growing with a CAGR of 7.40% during the forecast period 2026-2031. The Alpha Thalassemia Mark...
March 2025
43 pages
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Central Nervous System Infections, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others)...
March 2025
406 pages
Heparin Market Size, Share, Trends and Forecast by Product, Source, Mode of Administration, Application, End-User, Distribution Channel, and Region 2025-2033
US$ 2,999.00
The global heparin market size was valued at USD 7.46 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.02 Billion by 2033, exhibiting a CAGR of 2.12% during 2025-2033....
March 2025
145 pages
Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (Mass Spectrometry, PCR, In Situ Hybridization), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within Immediate Infectious Disease Molecular Diagnostics Market Growth & Trends The global infectious disease molecular diagnostics market size is expect...
February 2025
100 pages
Albendazole Anthelmintic Drug Market - 2024-2031
US$ 3,400.00
Albendazole Anthelmintic Drug Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Albendazole Anthelmintic Drug Market emerges as a key focus in DataM Intelligence lates...
February 2025
55 pages
Hypovolemic Shock Market - 2024-2031
US$ 3,400.00
The Hypovolemic Shock Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...
February 2025
43 pages
Hypereosinophilic Syndrome Market - 2024-2031
US$ 3,400.00
Hypereosinophilic Syndrome Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Hypereosinophilic Syndrome Market emerges as a key focus in DataM Intelligence latest in-d...
February 2025
52 pages
STD Self-Testing Market Size, Share & Trends Analysis Report By Application (CT/NG Testing, Syphilis Testing, HIV Testing), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days STD Self-Testing Market Growth & Trends The global STD self testing market size is expected t%li%reach USD 1.98 billion by 2030, ac...
February 2025
150 pages
Europe Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Molecular, Conventional), By Infection Type (UTI, Pneumonia), By Product (Consumables, Instruments), By Type, By Country, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Europe Hospital Acquired Infections Diagnostics Market Growth & Trends The Europe hospital acquired infections diagnostics market s...
February 2025
100 pages
Europe Point-Of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Application (Infectious Disease, Oncology), By Test Location, By Technology (PCR Based, Genetic Sequencing Based), By End Use, By Country, And Segment Forecasts, 2025 - 2030
US$ 3,950.00
This report can be delivered to the clients within 3 Business Days Europe Point-of-Care Molecular Diagnostics Market Growth & Trends The Europe point-of-care molecular diagnostics market size is ant...
February 2025
100 pages
Immune Checkpoint Inhibitors Market - 2024-2031
US$ 3,400.00
Immune Checkpoint Inhibitors Market reached US$ 40.1 billion in 2023 and is expected to reach US$ 156.6 billion by 2031, growing with a CAGR of 16.50% during the forecast period 2026-2031. The Immune...
February 2025
54 pages
North America And Europe Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Pathogen, By Testing, By Method, By End Use, By Country, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days North America And Europe Sepsis Diagnostics Market Growth & Trends The North America and Europe sepsis diagnostics market size is a...
February 2025
100 pages
